| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测服务收入(元) | 32,208,921.13 | 84,935,851.14 | 44,743,728.77 | 135,004,439.77 | 73,695,734.72 |
| 检测试剂收入(元) | 447,818,918.25 | 859,875,765.97 | 383,573,600.20 | 611,385,503.41 | 295,083,452.30 |
| 药物临床研究服务(元) | 59,987,816.73 | 88,706,635.50 | 25,411,066.30 | 86,038,440.23 | 18,367,903.90 |
| 营业成本(元) | |||||
| 检测服务收入(元) | 15,633,632.48 | 54,261,873.94 | 25,528,426.88 | 53,982,790.39 | 29,656,865.80 |
| 检测试剂收入(元) | 40,792,979.15 | 80,639,333.62 | 36,290,099.50 | 62,337,478.54 | 26,242,616.34 |
| 药物临床研究服务(元) | 22,223,276.45 | 25,945,760.37 | 9,922,750.37 | 23,317,680.42 | 5,507,185.75 |
| 毛利(元) | |||||
| 检测服务收入(元) | 16,575,288.65 | 30,673,977.20 | 19,215,301.89 | 81,021,649.38 | 44,038,868.92 |
| 检测试剂收入(元) | 407,025,939.10 | 779,236,432.35 | 347,283,500.70 | 549,048,024.87 | 268,840,835.96 |
| 药物临床研究服务(元) | 37,764,540.28 | 62,760,875.13 | 15,488,315.93 | 62,720,759.81 | 12,860,718.15 |
| 毛利率(%) | |||||
| 检测服务收入(%) | 51.46 | 36.11 | 42.95 | 60.01 | 59.76 |
| 检测试剂收入(%) | 90.89 | 90.62 | 90.54 | 89.80 | 91.11 |
| 药物临床研究服务(%) | 62.95 | 70.75 | 60.95 | 72.90 | 70.02 |
| 收入构成(%) | |||||
| 检测服务收入(%) | 5.96 | 8.22 | 9.86 | 16.22 | 19.04 |
| 检测试剂收入(%) | 82.93 | 83.20 | 84.54 | 73.45 | 76.22 |
| 药物临床研究服务(%) | 11.11 | 8.58 | 5.60 | 10.34 | 4.74 |
| 毛利构成(%) | |||||
| 检测服务收入(%) | 3.59 | 3.51 | 5.03 | 11.69 | 13.52 |
| 检测试剂收入(%) | 88.22 | 89.29 | 90.91 | 79.25 | 82.53 |
| 药物临床研究服务(%) | 8.19 | 7.19 | 4.05 | 9.05 | 3.95 |